Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Open access
2,053
Views
0
CrossRef citations to date
0
Altmetric
Drug Profile
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
Timo Vesikaria Nordic Research Network Oy, Tampere, FinlandCorrespondence[email protected]
View further author information
, View further author information
Joanne M Langleyb IWK and Nova Scotia Health, Canadian Center for Vaccinology Dalhousie University, Halifax, CanadaView further author information
, Vlad Popovicc VBI Vaccines Inc, Cambridge, Massachusetts, USAView further author information
& Francisco Diaz-Mitomac VBI Vaccines Inc, Cambridge, Massachusetts, USAView further author information
Pages 1041-1054
|
Received 01 Mar 2023, Accepted 19 Oct 2023, Published online: 06 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.